« Previous
Next »
Nuclear Medicine and Biology
Volume 36, Issue 7
, Pages
759-770
, October 2009
177Lu- labeled MOv18 as compared to 131I- or 90Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts
To access this article, please choose from the options below
PII: S0969-8051(09)00129-2
doi: 10.1016/j.nucmedbio.2009.05.004
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Nuclear Medicine and Biology
Volume 36, Issue 7
, Pages
759-770
, October 2009
